Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and dalteparin

adenosine diphosphate has been researched along with dalteparin in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (40.00)18.2507
2000's6 (40.00)29.6817
2010's2 (13.33)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Colman, RW; Edmunds, LH; Gikakis, N; Gorman, JH; Hack, CE; Hiramatsu, Y; Khan, MM; Niewiarowski, S; Rao, AK; Sun, L1
Burgess, JK; Chong, BH1
Bentley, R; Bostwick, JS; Dunwiddie, CT; Kasiewski, CJ; Leadley, RJ; McVey, MJ; Perrone, MH; White, FJ1
Mann, KG; Schneider, DJ; Sobel, BE; Tracy, PB1
Théroux, P; Xiao, Z1
Farrell, TP; Hayes, KB; Schneider, DJ; Sobel, BE1
Badimon, JJ; Chesebro, JH; Fuster, V; Rauch, U; Reis, ED; Roqué, M1
Aggarwal, A; Schneider, DJ; Sobel, BE1
Heptinstall, S; May, JA; Storey, RF1
Barbanti, M; Cerletti, C; de Gaetano, G; Di Fabio, G; Donati, MB; Maugeri, N1
Ajayi, AA; Cooper, J; Horn, EH; Pharmacols, FB; Rubin, PC1
Goodall, AH; Hayes, PD; Jones, CI; McMahon, GS; Naylor, AR; Webster, SE1
Goodall, AH; Hayes, PD; Jones, CI; McMahon, GS; Naylor, AR1
Alotti, N; Aradi, D; Barabás, E; Dézsi, DA; Faluközy, J; Merkely, B; Skopál, J; Várnai, K; Veress, G1
Fujiwara, I; Iwasa, M; Kanematsu, Y; Koike, R; Komatsu, H; Maéda, Y; Moritsugu, K; Nagae, T; Narita, A; Oda, T; Ota, M; Takano, Y; Takeda, S; Tanaka, K; Watanabe, N1

Trials

3 trial(s) available for adenosine diphosphate and dalteparin

ArticleYear
Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.
    Circulation, 1998, Jan-27, Volume: 97, Issue:3

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Enoxaparin; Female; Heparin; Humans; Male; Middle Aged; P-Selectin; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides

1998
Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2009, Volume: 37, Issue:6

    Topics: Adenosine Diphosphate; Aged; Anticoagulants; Arachidonic Acid; Aspirin; Carotid Artery Diseases; Dalteparin; Double-Blind Method; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial

2009
Transient heparin-induced platelet activation linked to generation of platelet 12-lipoxygenase. Findings from a randomised controlled trial.
    Thrombosis and haemostasis, 2013, Volume: 109, Issue:6

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adenosine Diphosphate; Aged; Arachidonate 12-Lipoxygenase; Aspirin; Blood Platelets; Dalteparin; Endarterectomy, Carotid; Female; Gene Expression Regulation, Enzymologic; Heparin; Humans; Lipase; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Thromboxane B2

2013

Other Studies

12 other study(ies) available for adenosine diphosphate and dalteparin

ArticleYear
Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation.
    Circulation, 1996, Nov-01, Volume: 94, Issue:9 Suppl

    Topics: Adenosine Diphosphate; Arthropod Proteins; Complement Activation; Complement C1 Inactivator Proteins; Enoxaparin; Extracorporeal Circulation; Factor Xa Inhibitors; Humans; Intercellular Signaling Peptides and Proteins; Neutrophil Activation; Peptides; Recombinant Proteins; Thrombin

1996
The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.
    European journal of haematology, 1997, Volume: 58, Issue:4

    Topics: Adenosine Diphosphate; Adult; Aged; Anticoagulants; Chondroitin Sulfates; Critical Illness; Dalteparin; Dermatan Sulfate; Drug Synergism; Enoxaparin; Epinephrine; Female; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation; Reference Values

1997
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Thrombosis and haemostasis, 1997, Volume: 78, Issue:4

    Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Collagen; Coronary Thrombosis; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Hemostasis; Heparin; Hirudin Therapy; Hirudins; Male; Partial Thromboplastin Time; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin; Prothrombin Time; Recombinant Proteins; Recurrence; Safety; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator

1997
Differential effects of anticoagulants on the activation of platelets ex vivo.
    Circulation, 1997, Nov-04, Volume: 96, Issue:9

    Topics: Adenosine Diphosphate; Anticoagulants; Collagen; Edetic Acid; Enoxaparin; Female; Heparin; Humans; Male; Platelet Activation

1997
The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
    The American journal of cardiology, 1999, Mar-01, Volume: 83, Issue:5

    Topics: Adenosine Diphosphate; Adult; Analysis of Variance; Anticoagulants; Aspirin; Chemoprevention; Citric Acid; Collagen; Drug Interactions; Enoxaparin; Factor XIIa; Flow Cytometry; Humans; Male; P-Selectin; Plant Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Trypsin Inhibitors; Zea mays

1999
Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury.
    Thrombosis research, 2000, Jun-15, Volume: 98, Issue:6

    Topics: Adenosine Diphosphate; Animals; Arteries; Blood Coagulation Tests; Blood Flow Velocity; Collagen; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hematologic Tests; Heparin; Heparin, Low-Molecular-Weight; Perfusion; Platelet Aggregation; Platelet Function Tests; Swine; Thrombosis

2000
Decreased platelet reactivity in blood anticoagulated with bivalirudin or enoxaparin compared with unfractionated heparin: implications for coronary intervention.
    Journal of thrombosis and thrombolysis, 2002, Volume: 13, Issue:3

    Topics: Adenosine Diphosphate; Aged; Anticoagulants; Coronary Artery Disease; Drug Evaluation; Enoxaparin; Flow Cytometry; Heparin; Hirudins; Humans; Middle Aged; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins

2002
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Thrombosis research, 2005, Volume: 115, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Degranulation; Dalteparin; Drug Synergism; Heparin; Hirudins; Humans; In Vitro Techniques; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12

2005
Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

    Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Blood Platelets; CD11b Antigen; CD40 Antigens; Cell Adhesion; Collagen; Dose-Response Relationship, Drug; Enoxaparin; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; In Vitro Techniques; Leukocytes; P-Selectin; Peptide Fragments; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stress, Mechanical; Thrombin; Thromboplastin

2007
Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Methods and findings in experimental and clinical pharmacology, 2007, Volume: 29, Issue:8

    Topics: Adenosine Diphosphate; Adult; Analysis of Variance; Anticoagulants; Apyrase; Blood Platelets; Dalteparin; Enoxaparin; Female; Heparin; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Count; Pregnancy; Pregnancy Trimester, Third

2007
Impact of Test Conditions on ADP-Induced Platelet Function Results With the Multiplate Assay: Is Further Standardization Required?
    Journal of cardiovascular pharmacology and therapeutics, 2018, Volume: 23, Issue:2

    Topics: Adenosine Diphosphate; Aged; Anticoagulants; Blood Platelets; Clopidogrel; Drug Monitoring; Drug Stability; Enoxaparin; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Reproducibility of Results; Specimen Handling; Time Factors

2018
Structures and mechanisms of actin ATP hydrolysis.
    Proceedings of the National Academy of Sciences of the United States of America, 2022, 10-25, Volume: 119, Issue:43

    Topics: Actins; Adenosine Diphosphate; Adenosine Triphosphate; Dalteparin; Hydrolysis; Myosins; Protons; Water

2022